Transcode Therapeutics P/TBV

Price to Tangible Book Value (P/TBV) of Transcode Therapeutics is -4.23 in 2026.

Price to Tangible Book Value (P/TBV) of Transcode Therapeutics changed from 5.20 to -4.23, representing a -181.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Transcode Therapeutics with sector peers and the industry average to assess whether it is attractive.